Open access · CC-BY
via OpenAlex
Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link
Frontiers in Cellular Neuroscience · 2022 · ▲ 37 citations
Abstract
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease worldwide. With the increasing trend of population aging, the estimated number of AD continues to climb, causing enormous medical, social and economic burden to the society. Currently, no drug is available to cure the disease or slow down its progression. There is an urgent need to improve our understanding on the pathogenesis of AD and develop novel therapy to combat it. Despite the two well-known pathological hallmarks (extracellular amyloid plaques and intracellular Neurofibrillary Tangles), the exact mechanisms for selective degeneration and loss of neurons and synapses in AD remain to be elucidated. Cumulative studies have shown neuroinflammation plays a central role in pathogenesis of AD. Neuroinflammation is actively involved both in the onset and the subsequent progression of AD. Microglia are the central player in AD neuroinflammation. In this review, we first introduced the different theories proposed for the pathogenesis of AD, focusing on neuroinflammation, especially on microglia, systemic inflammation, and peripheral and central immune system crosstalk. We explored the possible mechanisms of action of stem cell therapy, which is the only treatment modality so far that has pleiotropic effects and can target multiple mechanisms in AD. Mesenchymal stem cells are currently the most widely used stem cell type in AD clinical trials. We summarized the ongoing major mesenchymal stem cell clinical trials in AD and showed how translational stem cell therapy is bridging the gap between basic science and clinical intervention in this devastating disorder.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fncel.2021.811852
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Hu, J., & Wang, X. (2022). Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link. <em>Frontiers in Cellular Neuroscience</em>. https://doi.org/10.3389/fncel.2021.811852
Vancouver
Hu J, Wang X. Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link. Frontiers in Cellular Neuroscience. 2022. doi:10.3389/fncel.2021.811852.
BibTeX
@article{jingqiong2022Alzhei,
title = {Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link},
author = {Jingqiong Hu and Xiaochuan Wang},
journal = {Frontiers in Cellular Neuroscience},
year = {2022},
doi = {10.3389/fncel.2021.811852},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cell Research & Therapy 2021
Open access · CC-BY
Advances in mesenchymal stem cell exosomes: a review
World Journal of Stem Cells 2014
Open access · CC-BY
Progress of mesenchymal stem cell therapy for neural and retinal diseases
Smart Medicine 2022
Open access · CC-BY
Reprogramming stem cells in regenerative medicine
Bulletin Biomedicine and sociology 2024
Citation only
MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM
Circulation Research 2015
Open access · OA
Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease
Journal of Clinical Orthopaedics and Trauma 2016
Open access · OA